RRFDX
Price
$36.89
Change
-$0.02 (-0.05%)
Updated
Aug 15 closing price
Net Assets
16.24B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

RRFDX vs VVIAX

Header iconRRFDX vs VVIAX Comparison
Open Charts RRFDX vs VVIAXBanner chart's image
T. Rowe Price Equity Income R
Price$36.89
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets16.24B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
RRFDX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RRFDX vs. VVIAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRFDX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. RRFDX (16.2B). VVIAX pays higher dividends than RRFDX: VVIAX (2.18) vs RRFDX (1.27). RRFDX was incepted earlier than VVIAX: RRFDX (23 years) vs VVIAX (25 years). RRFDX (1.25) is less costly to investors than VVIAX (0.05). RRFDX is a more actively managed with annual turnover of: 21.40 vs. VVIAX (9.00). RRFDX has a lower initial minimum investment than VVIAX: RRFDX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 8.04 vs. RRFDX (1.71). VVIAX return over 5 years is better than : 68.75 vs. RRFDX (41.83).
RRFDXVVIAXRRFDX / VVIAX
Total Expense Ratio1.250.052,500%
Annual Report Gross Expense Ratio1.250.052,500%
Fund Existence23 years25 years-
Gain YTD7.9146.653119%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets16.2B196B8%
Annual Yield % from dividends1.272.1858%
Returns for 1 year1.718.0421%
Returns for 3 years8.2926.0932%
Returns for 5 years41.8368.7561%
Returns for 10 years31.36114.8827%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXW20.820.36
+1.76%
CoreCivic
NBIX132.901.59
+1.21%
Neurocrine Biosciences
ZENV1.640.01
+0.49%
Zenvia
ATYR4.90-0.09
-1.80%
aTyr Pharma Inc
WNW1.69-0.05
-2.80%
Meiwu Technology Company Limited